Myriad Genetics (MYGN): Biggest Revenue Beat In 2yrs - Jefferies

February 8, 2017 7:34 AM

Jefferies analyst, Brandon Couillard, reiterated his Hold rating on shares of Myriad Genetics (NASDAQ: MYGN) even though MYGN posted its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found